Intersections between mitochondrial sirtuin signaling and tumor cell metabolism

References

• Ahn B-H, Kim H-S, Song S, et al. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 105:14447–52
   PubMed Web of Science ®Google Scholar
• Ahuja N, Schwer B, Carobbio S, et al. (2007). Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282:33583–92
   PubMed Web of Science ®Google Scholar
• Alhazzazi TY, Kamarajan P, Joo N, et al. (2011). Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 117:1670–8
   PubMed Web of Science ®Google Scholar
• Andrés A, Satrústegui J, Machado A. (1980). Development of NADPH-producing pathways in rat heart. Biochem J 186:799–803
   PubMed Web of Science ®Google Scholar
• Bao X, Wang Y, Li X, et al. (2014). Identification of “erasers” for lysine crotonylated histone marks using a chemical proteomics approach. Elife 3:e02999
   Web of Science ®Google Scholar
• Bause AS, Haigis MC. (2013). SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol 48:634–9
   PubMed Web of Science ®Google Scholar
• Baysal BE, Willett-Brozick JE, Filho PAA, et al. (2004). An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 41:703–9
   PubMed Web of Science ®Google Scholar
• Bell EL, Emerling BM, Ricoult, et al. (2011). SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30:2986–96
   PubMed Web of Science ®Google Scholar
• Bellacosa A, Kumar CC, Di Cristofano A, et al. (2005). Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94:29–86
   PubMed Web of Science ®Google Scholar
• Ben-Sahra I, Howell JJ, Asara JM, Manning BD. (2013). Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339:1323–8
   PubMed Web of Science ®Google Scholar
• Benhar M, Engelberg D, Levitzki A. (2002). ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3:420–5
   PubMed Web of Science ®Google Scholar
• Bharathi SS, Zhan Y, Mohsen A-W, et al. (2013). Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site. J Biol Chem 288:33837–47
   PubMed Web of Science ®Google Scholar
• Boros LG, Torday JS, Lim S, et al. (2000). Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60:1183–5
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. (2011). Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95
   Google Scholar
• Cantor JR, Sabatini DM. (2012). Cancer cell metabolism: one hallmark, many faces. Cancer Discov 2:881–98
   PubMed Web of Science ®Google Scholar
• Chang Y. (2005). KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46:2624–35
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang J, Lin Y, et al. (2011). Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 12:534–41
   PubMed Web of Science ®Google Scholar
• Christofk HR, Vander Heiden MG, Harris MH, et al. (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–3
   PubMed Web of Science ®Google Scholar
• Courtney KD, Corcoran RB, Engelman JA. (2010). The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075–83
   PubMed Web of Science ®Google Scholar
• Csibi A, Fendt S-M, Li C, et al. (2013). The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153:840–54
   PubMed Web of Science ®Google Scholar
• Dang CV. (2012a). Cancer cell metabolism: there is no ROS for the weary. Cancer Discov 2:304–7
   PubMed Web of Science ®Google Scholar
• Dang CV. (2012b). Links between metabolism and cancer. Genes Dev 26:877–90
   PubMed Web of Science ®Google Scholar
• Dang CV. (2013). MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3:a014217. doi: 10.1101/cshperspect.a014217
   Google Scholar
• Daye D, Wellen KE. (2012). Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Sem Cell Dev Biol 23:362–9
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ. (2008). Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med 10:767–77
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. (2009). Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29:313–24
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Thompson CB. (2012). Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148:1132–44
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Mancuso A, Daikhin E, et al. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–50
   Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20
   PubMed Web of Science ®Google Scholar
• Denko NC. (2008). Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705–13
   PubMed Web of Science ®Google Scholar
• Downward J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11–22
   PubMed Web of Science ®Google Scholar
• Düvel K, Yecies JL, Menon S, et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–83
   PubMed Web of Science ®Google Scholar
• Easlon E, Tsang F, Skinner C, et al. (2008). The malate-aspartate NADH shuttle components are novel metabolic longevity regulators required for calorie restriction-mediated life span extension in yeast. Genes Dev 22:931–44
   PubMed Web of Science ®Google Scholar
• Finley LWS, Haigis MC. (2012). Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 18:516–23
   PubMed Web of Science ®Google Scholar
• Finley LWS, Carracedo A, Lee J, et al. (2011a). SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19:416–28
   PubMed Web of Science ®Google Scholar
• Finley LWS, Haas W, Desquiret-Dumas V, et al. (2011b). Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS One 6:e23295
   PubMed Web of Science ®Google Scholar
• Frye RA. (1999). Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260:273–9
   PubMed Web of Science ®Google Scholar
• Gaglio D, Metallo CM, Gameiro PA, et al. (2011). Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 7:523
   PubMed Web of Science ®Google Scholar
• Gao P, Tchernyshyov I, Chang T-C, et al. (2009). c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762–5
   PubMed Web of Science ®Google Scholar
• Garrett R, Grisham C. (2012). Biochemistry. Belmont (CA): Cengage Learning
   Google Scholar
• Gerhart-Hines Z, Rodgers JT, Bare O, et al. (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26:1913–23
   PubMed Web of Science ®Google Scholar
• Greenberg DM, Ichihara A. (1957). Further studies on the pathway of serine formation from carbohydrate. J Biol Chem 224:331–40
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. (2005). An expanding role for mTOR in cancer. Trends Mol Med 11:353–61
   PubMed Web of Science ®Google Scholar
• Haigis MC, Guarente LP. (2006). Mammalian sirtuins – emerging roles in physiology, aging, and calorie restriction. Genes Dev 20:2913–21
   PubMed Web of Science ®Google Scholar
• Haigis MC, Mostoslavsky R, Haigis KM, et al. (2006). SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126:941–54
   PubMed Web of Science ®Google Scholar
• Hallows WC, Yu W, Smith BC, et al. (2011). Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell 41:139–49
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144:646–74
   PubMed Web of Science ®Google Scholar
• Hebert AS, Dittenhafer-Reed KE, Yu W, et al. (2013). Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 49:186–99
   PubMed Web of Science ®Google Scholar
• Hers I, Vincent EE, Tavaré JM. (2011). Akt signalling in health and disease. Cell Signal 23:1515–27
   PubMed Web of Science ®Google Scholar
• Hirschey MD, Shimazu T, Goetzman E, et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121–5
   PubMed Web of Science ®Google Scholar
• Hornbeck PV, Zhang B, Murray B, et al. (2015). PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 43:D512–20
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Pirinen E. Auwerx J. (2012). Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13:225–38
   PubMed Web of Science ®Google Scholar
• Jacobs KM, Pennington JD, Bisht KS, et al. (2008). SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int J Biol Sci 4:291–9
   PubMed Web of Science ®Google Scholar
• Jeong SM, Lee A, Lee J, et al. (2013). SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23:450–63
   PubMed Web of Science ®Google Scholar
• Jeong SM, Lee A, Lee J, Haigis MC. (2014a). SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma. J Biol Chem 289:4135–44
   PubMed Web of Science ®Google Scholar
• Jeong SM, Lee J, Finley LW, et al. (2014b). SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1. Oncogene [Epub ahead of print]. doi: 10.1038/onc.2014.124
   Web of Science ®Google Scholar
• Jing E, Emanuelli B, Hirschey MD, et al. (2011). Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci USA 108:14608–1
   PubMed Web of Science ®Google Scholar
• Jones NP, Schulze A. (2012). Targeting cancer metabolism – aiming at a tumour's sweet-spot. Drug Discov Today 17:232–41
   PubMed Web of Science ®Google Scholar
• Jones RG, Thompson CB. (2009). Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23:537–48
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro S-H, et al. (2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20:1992–2003
   PubMed Web of Science ®Google Scholar
• Kaelin WG. (2002). Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673–82
   PubMed Web of Science ®Google Scholar
• Kaelin WG, Thompson CB. (2010). Q&A: cancer: clues from cell metabolism. Nature 465:562–4
   PubMed Web of Science ®Google Scholar
• Kim H-S, Patel K, Muldoon-Jacobs K, et al. (2010). SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41–52
   PubMed Web of Science ®Google Scholar
• Kim J, Tchernyshyov I, Semenza GL, Dang CV. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–85
   PubMed Web of Science ®Google Scholar
• Kincaid B, Bossy-Wetzel E. (2013). Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci 5:48. doi: 10.3389/fnagi.2013.00048
   PubMed Web of Science ®Google Scholar
• Kovacević Z. (1971). The pathway of glutamine and glutamate oxidation in isolated mitochondria from mammalian cells. Biochem J 125:757–63
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–22
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. (2009). mTOR signaling at a glance. J Cell Sci 122:3589–94
   PubMed Web of Science ®Google Scholar
• Laurent G, German NJ, Saha AK, et al. (2013). SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol Cell 50:686–98
   PubMed Web of Science ®Google Scholar
• Le A, Lane AN, Hamaker M, et al. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 15:110–21
   PubMed Web of Science ®Google Scholar
• Levine AJ, Puzio-Kuter AM. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340–4
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu J, Feng Z. (2013). The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci 3:9. doi: 10.1186/2045-3701-3-9
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee Y-M, Chun Y-S, et al. (2010). Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol Cell 38:864–78
   PubMed Web of Science ®Google Scholar
• Lin CY, Lovén J, Rahl PB, et al. (2012). Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56–67
   PubMed Web of Science ®Google Scholar
• Lin Z-F, Xu H-B, Wang JY, et al. (2013). SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem Biophys Res Commun 441:191–5
   PubMed Web of Science ®Google Scholar
• Liu Y-C, Li F, Handler J, et al. (2008). Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One 3:e2722
   PubMed Web of Science ®Google Scholar
• Lo M, Wang YZ, Gout PW. (2008). The xc−cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215:593–602
   PubMed Web of Science ®Google Scholar
• Locasale JW, Grassian AR, Melman T, et al. (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43:869–74
   PubMed Web of Science ®Google Scholar
• Lombard DB, Alt FW, Cheng HL, et al. (2007). Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation. Mol Cell Biol 27:8807–14
   PubMed Web of Science ®Google Scholar
• Lora J, Alonso FJ, Segura JA, et al. (2004). Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem/FEBS 271:4298–306
   PubMedGoogle Scholar
• Lu SC. (2009). Regulation of glutathione synthesis. Mol Aspects Med 30:42–59
   PubMed Web of Science ®Google Scholar
• Lu SC. (2013). Glutathione synthesis. Biochim Biophys Acta 1830:3143–53
   PubMed Web of Science ®Google Scholar
• Lu W, Zuo Y, Feng Y, Zhang M. (2014). SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer. Tumor Biol 35:10699–705
   PubMed Web of Science ®Google Scholar
• Lu W, Pelicano H, Huang P. (2010). Cancer metabolism: is glutamine sweeter than glucose? Cancer Cell 18:199–200
   PubMed Web of Science ®Google Scholar
• Lukey MJ, Wilson KF, Cerione RA. (2013). Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem 5:1685–700
   PubMed Web of Science ®Google Scholar
• Lunt SY, Vander Heiden MG. (2011). Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441–64
   PubMed Web of Science ®Google Scholar
• Marshall S, Bacote V, Traxinger RR. (1991). Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706–12
   PubMed Web of Science ®Google Scholar
• Martini M, De Santis MC, Braccini M, et al. (2014). PI3K/AKT signaling pathway and cancer: an updated review. Ann Med 46:372–83
   PubMed Web of Science ®Google Scholar
• Marxsen JH, Stengel P, Doege K, et al. (2004). Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381:761–7
   PubMed Web of Science ®Google Scholar
• Matés JM, Segura JA, Campos-Sandoval JA, et al. (2009). Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol 41:2051–61
   Google Scholar
• Mathias RA, Greco TM, Oberstein A, et al. (2014). Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159:1615–25
   PubMed Web of Science ®Google Scholar
• Matsuno T. (1989). End products of glutamine oxidation in MC-29 virus-induced chicken hepatoma mitochondria. Biochem Med Metab Biol 42:125–31
   PubMedGoogle Scholar
• Matsushita N, Yonashiro R, Ogata Y, et al. (2010). Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes Cells 16:190–202
   PubMed Web of Science ®Google Scholar
• McBride HM, Neuspiel M, Wasiak S. (2006). Mitochondria: more than just a powerhouse. Curr Biol 16:R551–60
   PubMed Web of Science ®Google Scholar
• Menon S, Manning BD. (2008). Common corruption of the mTOR signaling network in human tumors. Oncogene 27:S43–51
   PubMedGoogle Scholar
• Metallo CM, Gameiro PA, Bell EL, et al. (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380–4
   PubMed Web of Science ®Google Scholar
• Miller DM, Thomas SD, Islam A, et al. (2012). c-Myc and cancer metabolism. Clin Cancer Res 18:5546–53
   PubMed Web of Science ®Google Scholar
• Mitsuishi Y, Taguchi K, Kawatani Y, et al. (2012). Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22:66–79
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Lomb DJ, Haigis MC, et al. (2009). SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137:560–70
   PubMed Web of Science ®Google Scholar
• Nicklin P, Bergman P, Zhang B, et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521–34
   PubMed Web of Science ®Google Scholar
• Nie Z, Hu G, Wei G, et al. (2012). c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68–79
   PubMed Web of Science ®Google Scholar
• Ortega AL, Mena S, Estrela JM. (2011). Glutathione in cancer cell death. Cancer 3:1285–310
   Google Scholar
• Ouaïssi M, Sieleznef I, Silvester R, et al. (2008). High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas. Ann Surg Oncol 15:2318–28
   PubMed Web of Science ®Google Scholar
• Papandreou I, Cairns RA, Fontana L, et al. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–97
   PubMed Web of Science ®Google Scholar
• Park J, Chen Y, Tishkoff DX, et al. (2013). SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 50:919–30
   PubMed Web of Science ®Google Scholar
• Pearce EL, Pearce EJ. (2013). Metabolic pathways in immune cell activation and quiescence. Immunity 38:633–43
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, Huang P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 7:97–110
   PubMed Web of Science ®Google Scholar
• Peng C, Lu Z, Xie Z, et al. (2011). The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics 10: M111.012658
   Web of Science ®Google Scholar
• Pfister JA, Ma C, Morrison BE, et al. (2008). Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 3:e4090
   PubMed Web of Science ®Google Scholar
• Pillai VB, Sundaresan NR, Kim G, et al. (2010). Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133–44
   PubMed Web of Science ®Google Scholar
• Pillai VB, Sundaresan NR, Gupta MP. (2014). Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ Res 114:368–78
   PubMed Web of Science ®Google Scholar
• Polat MF, Taysi S, Gul M, et al. (2002). Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 20:327–31
   PubMed Web of Science ®Google Scholar
• Possemato R, Marks KM, Shaul YD, et al. (2011). Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476:346–50
   PubMed Web of Science ®Google Scholar
• Qiu X, Brown K, Hirschey MD, et al. (2010). Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–7
   PubMed Web of Science ®Google Scholar
• Rao KN, Elm MS, Kelly RH, et al. (1997). Hepatic hyperplasia and cancer in rats: metabolic alterations associated with cell growth. Gastroenterology 113:238–48
   PubMed Web of Science ®Google Scholar
• Rardin MJ, He W, Nishida Y, et al. (2013). SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 18:920–33
   PubMed Web of Science ®Google Scholar
• Ray PD, Huang B-W, Tsuji Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981–90
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, et al. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113–18
   PubMed Web of Science ®Google Scholar
• Roth M, Chen WY. (2014). Sorting out functions of sirtuins in cancer. Oncogene 33:1609–20
   PubMed Web of Science ®Google Scholar
• Sabine JR, Kopelovich L, Abraham S, et al. (1973). Control of lipid metabolism in hepatomas: conversion of glutamate carbon to fatty acid carbon via citrate in several transplantable hepatomas. Biochim Biophys Acta 296:493–8
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, et al. (1999). Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455–8
   PubMed Web of Science ®Google Scholar
• Schieber M, Chandel NS. (2014). ROS function in redox signaling and oxidative stress. Curr Biol 24:R453–62
   PubMed Web of Science ®Google Scholar
• Schlicker C, Gertz M, Papatheodorou P, et al. (2008). Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382:790–801
   PubMed Web of Science ®Google Scholar
• Schulze A, Harris AL. (2012). How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491:364–73
   PubMed Web of Science ®Google Scholar
• Schumacker PT. (2006). Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175–6
   PubMed Web of Science ®Google Scholar
• Sears R, Nuckolls F, Haura E, et al. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501–14
   PubMed Web of Science ®Google Scholar
• Sebastian C, Satterstrom FK, Haigis MC, et al. (2012a). From sirtuin biology to human diseases: an update. J Biol Chem 287:42444–52
   PubMed Web of Science ®Google Scholar
• Sebastian C, Zwaans BMM, Silberman DM, et al. (2012b). The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151:1185–99
   PubMed Web of Science ®Google Scholar
• Selak MA, Armour SM, MacKenzie ED, et al. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7:77–85
   PubMed Web of Science ®Google Scholar
• Semenza GL. (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J App Physiol 88:1474–80
   PubMed Web of Science ®Google Scholar
• Semenza GL. (2010). HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20:51–6
   PubMed Web of Science ®Google Scholar
• Shi T, Fan GQ, Xiao SD. (2010). SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J Dig Dis 11:55–62
   PubMed Web of Science ®Google Scholar
• Shin J, He M, Liu Y, et al. (2013). SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep 5:654–65
   PubMed Web of Science ®Google Scholar
• Someya S, Yu W, Hallows WC, et al. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:802–12
   PubMed Web of Science ®Google Scholar
• Son J, Lyssiotis CA, Ying H, et al. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101–5
   PubMed Web of Science ®Google Scholar
• Sun Q, Chen X, Ma J, et al. (2011). Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci USA 108:4129–34
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Gupta M, Kim G, et al. (2009). Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119:2758–71
   PubMed Web of Science ®Google Scholar
• Tan M, Peng C, Anderson KA, et al. (2014). Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab 19:605–17
   PubMed Web of Science ®Google Scholar
• Tao R, Coleman MC, Pennington JD, et al. (2010). Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 40:893–904
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. (2000). Reactive oxygen species in cell signaling. Am J Physiol 279:L1005–28
   PubMed Web of Science ®Google Scholar
• Tomlinson IPM, Alam NA, Rowan AJ, et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–10
   PubMed Web of Science ®Google Scholar
• Tong X, Zhao F, Thompson CB. (2009). The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 19:32–7
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579–91
   PubMed Web of Science ®Google Scholar
• Van Driel BE, Valet GK, Lyon H, et al. (1999). Prognostic estimation of survival of colorectal cancer patients with the quantitative histochemical assay of G6PDH activity and the multiparameter classification program CLASSIF1. Cytometry 38:176–83
   PubMedGoogle Scholar
• Vander Heiden MG, Lunt SY, Dayton TL, et al. (2012). Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol 76:325–34
   Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–33
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, et al. (2011). The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35:871–82
   PubMed Web of Science ®Google Scholar
• Warburg O, Wind F, Negelein E. (1927). The metabolism of tumors in the body. J Gen Physiol 8:519–30
   PubMedGoogle Scholar
• Ward PS, Thompson CB. (2012). Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:297–308
   PubMed Web of Science ®Google Scholar
• Weinert BT, Schölz C, Wagner SA, et al. (2013). Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep 4:842–51
   PubMed Web of Science ®Google Scholar
• Weinhouse S. (1976). The Warburg hypothesis fifty years later. Zeitschrift für Krebsforschung und klinische Onkologie. Cancer Res Clin Oncol 87:115–26
   Google Scholar
• Wellen KE, Thompson CB. (2012). A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13:270–6
   PubMed Web of Science ®Google Scholar
• Wellen KE, Lu C, Mancuso A, et al. (2010). The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev 24:2784–99
   PubMed Web of Science ®Google Scholar
• Wise DR, DeBerardinis RJ, Mancuso A, et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105:18782–7
   PubMed Web of Science ®Google Scholar
• Wise DR, Ward PS, Shay JES, et al. (2011). Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci USA 108:19611–16
   PubMed Web of Science ®Google Scholar
• Wu G, Fang Y-Z, Yang S, et al. (2004). Glutathione metabolism and its implications for health. J Nutr 134:489–92
   PubMed Web of Science ®Google Scholar
• Xu Y, Li F, Lv L, et al. (2014). Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase. Cancer Res 74:3630–42
   PubMed Web of Science ®Google Scholar
• Yang MH, Laurent G, Bause AS, et al. (2013). HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol Cancer Res 11:1072–7
   PubMed Web of Science ®Google Scholar
• Yecies JL, Manning BD. (2011a). mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med 89:221–8
   PubMed Web of Science ®Google Scholar
• Yecies JL, Manning BD. (2011b). Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res 71:2815–20
   Google Scholar
• Ying H, Kimmelman AC, Lyssiotis CA, et al. (2012). Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:656–70
   PubMed Web of Science ®Google Scholar
• Yu W, Dittenhafer-Reed KE, Denu JM. (2012). SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287:14078–86
   PubMed Web of Science ®Google Scholar
• Yuan J, Minter-Dykhouse K, Lou Z. (2009). A c-Myc–SIRT1 feedback loop regulates cell growth and transformation. J Cell Biol 185:203–11
   PubMed Web of Science ®Google Scholar
• Yuneva M, Zamboni N, Oefner P, et al. (2007). Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178:93–105
   PubMed Web of Science ®Google Scholar
• Zhong H, De Marzo AM, Laughner E, et al. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5
   PubMed Web of Science ®Google Scholar